Since AMA-M2 is a hallmark antibody of primary biliary cholangitis (PBC), and PBC patients typically show elevated IgM levels [41], ACA-positive pSS patients may be at an enhanced risk for developing PBC, potentially due to dysregulated CD16+CD56+ NK cell activation. This evidence concerns the gene CD40LG and primary biliary cholangitis.